Artesunate suppositories work with artemisinin suppositories in severe malaria was conducted in Viet Nam in the early 1990s, and clinical trials of rectal artesunate followed by mefloquine treatment in moderately severe malaria were conducted in the mid-1990s in Thailand. A major placebo-controlled clinical trial published in 2009 found that "if patients with severe malaria cannot be treated orally and access to injections will take several hours, a single inexpensive artesunate [rectal] suppository at the time of referral substantially reduces the risk of death or permanent disability." Artesunate suppositories Artesunate suppositories are used for the treatment of malaria. Artesunate is an antimalarial water-soluble
International Association for the Treatment of Sexual Offenders and treatment targets (such as cognitive distortions). Responsivity issues are the parts that affect how much the client(s) benefit or fail to benefit from the treatment and care programs. This proves that the treatment of sexual offenders has to be specific and different than another offenders treatment. Treatment of sexual offenders is very complicated and it is crucial to take the proper guidelines for the treatment to not only be successful but also to be long-lasting. Youths between the ages of 12-18 who have been either officially charged with a sexual crime or have performed an act that could be